Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Cash flows from operating activities:              
Net loss $ (4,974) $ (4,146) $ (4,809) $ (5,609) $ (13,528) $ (17,470)  
Adjustments to reconcile net loss to net cash flows from operating activities:              
Allowance for credit losses (recoveries)         (507) 903  
Depreciation and amortization         740 443  
Share-based compensation         5,204 4,536  
Amortization of debt issuance costs and original issue discounts         51 42  
Amortization of lease right-of-use, net of accretion in lease liabilities         692 590  
Accretion of discounts on short-term investments         0 (126)  
Increase (decrease) in cash resulting from changes in:              
Accounts receivable         (157) (662)  
Inventory, net         434 263  
Prepaid expenses and other current assets         88 241  
Other assets         (40) 22  
Accounts payable and accrued expenses         1,373 (1,023)  
Lease liabilities         (635) (553)  
Deferred revenue         (1,422) 243  
Net cash flows from operating activities         (7,707) (12,551) $ (13,700)
Cash flows from investing activities:              
Purchases of property and equipment         (12) (696)  
Acquisition of licensing rights         0 (167)  
Proceeds from maturities of short-term investments         0 10,000  
Net cash flows from investing activities         (12) 9,137  
Cash flows from financing activities:              
Proceeds from public offering of common stock, net of offering costs         16,183 0  
Repayment of 2020 senior secured convertible note         (10,000) 0  
Proceeds from stock option exercises         21 0  
Payments for taxes related to net share settlement of equity awards         (340) (173)  
Proceeds from issuance of common stock under employee stock purchase plan         288 314  
Net cash flows from financing activities         6,152 141  
Net change in cash and cash equivalents         (1,567) (3,273)  
Cash and cash equivalents, beginning of period   $ 23,140   $ 27,615 23,140 27,615 27,615
Cash and cash equivalents, end of period $ 21,573   $ 24,342   21,573 24,342 $ 23,140
Cash paid for:              
Income taxes         0 0  
Interest         $ 480 $ 554